Jamie Weishaar

Jamie Weishaar

VP, Global Commercial Drug Product

About

Jamie Weishaar is an experienced Business Development Executive leader specializing in Pharmaceutical Drug Development, including Contract Development and Manufacturing (CDMO) and Clinical Research Services. Currently, and recently in a new global role, he is focused on accelerating Drug Product Development through, Clinical and Commercial programs.

Jamie holds degree in Chemistry from Fort Hays State University and Masters in Analytical Chemistry from Washington State University.
 

Expertise & focus areas
Quotient Sciences Logo
Commercial Manufacturing, Pediatrics, Oncology

Quotient Sciences' Commercial Manufacturing Capabilities

Read More

Latest news from Quotient Sciences

More News
News & Announcements, Articles & Publications, commercial manufacturing, Dr. Helen Baker, Dr. Richard Castledine Dr. Helen Baker and Dr. Richard Castledine contribute to Pharmaceutical Technology's 'Poor API Quality Threatens a Healthy Supply' By: Dr. Helen Baker and Dr. Richard Castledine
Read More
News & Announcements, Articles & Publications, Thierry Van Nieuwenhove Thierry Van Nieuwenhove on the Future of CDMO Partnerships By: Thierry Van Nieuwenhove
Read More
News & Announcements, Translational Pharmaceutics®, Articles & Publications BioPharm International interviews Helen Baker about how Quotient Sciences is optimizing drug development
Read More